NCT06207929View on ClinicalTrials.gov

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections

CompletedOBSERVATIONAL
Enrollment

18,157

Participants

Timeline

Start Date

January 21, 2024

Primary Completion Date

August 7, 2024

Study Completion Date

August 7, 2024

Conditions
Influenza, HumanCOVID-19Influenza AInfluenza BRespiratory Syncytial Virus (RSV)
Trial Locations (1)

94402

Evidation Health, San Mateo

Sponsors

Lead Sponsor

Evidation Health
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Evidation Health

INDUSTRY